Precision Business Insights
Portfolio

 

Research Reports

Global Bevacizumab Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

Global Bevacizumab Market: By Application (Colorectal Cancer, Lung Cancer, Breast Cancer, Renal Cancer, Brain Cancer, Eye Diseases, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Geography

Global Bevacizumab Market Report Description:

Global bevacizumab market report gives comprehensive outlook on bevacizumab across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on global bevacizumab market gives historical, current, and future market sizes (US$ Mn) on the basis of application, distribution channel, and region. This report studies global bevacizumab market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global bevacizumab market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global bevacizumab market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global bevacizumab market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global bevacizumab products.

 

Global Bevacizumab Market:

The global bevacizumab market estimated to be valued US$ XX Mn in 2018 and poised to grow at significant CAGR over 2019-2025 due to increase in number of small cell lung cancers and rising adoption of unhealthy lifestyles, mainly in developing and developed countries which leads to change in eating, sleeping habits coupled with rising demand for personalized medicines, targeted therapies, platinum based chemotherapies, and availability of better diagnostic facilities are the major factors that are driving the growth of the bevacizumab market. Moreover, rising healthcare awareness and government initiatives fuels the growth of the market. However, high cost of treatment for cancers and side effects of cancer therapies are expected to hinder the growth of the market over the forecast period.

 

Increase in prevalence of cancer globally   

Ageing is one of the fundamental factor for the development of cancer. The incidence of cancer raises dramatically with age, most likely due to build-up risks for specific cancers that increases with age. According to WHO, cancer is the second leading cause of death globally, is responsible for an estimated 9.6 million deaths in 2018. Globally 1 in 6 deaths are due to cancer.  The increasing prevalence and incidence of cancer across the world increases the demand for bevacizumab.

 

North America Leads the Market with Highest Share in Global Bevacizumab Market

North America accounted for larger revenue share in global bevacizumab market with significant CAGR and is expected to grow with highest CAGR during the forecast period owing to presence of large number of prominent players and availability of reimbursement policies, rising adoption of new technologies and increasing healthcare awareness among the people about the early diagnosis. Europe and Asia Pacific market projected to grow at significant rate over the forecasted period owing to increasing aging population and presence of rapidly developing countries like India and China coupled with improvement in government funding dominates the bevacizumab market over the forecasted period.

 

Competition Assessment

Key player’s profiles in the global bevacizumab market include:

  • Genentech
  • Amgen
  • Allergan
  • Hoffmann-La Roche AG
  • Pfizer
  • Biocon
  • Celgene Corporation
  • Enzon Pharmaceuticals

Global bevacizumab market is surging owing to development of biosimilars and strategic collaborations among the market players to expand the portfolio and strengthen their position in the market. For instance, in September 2017, USFDA have approved the Amgen Inc’s Mvasi (bevacizumab-awwb), a biosimilar version of Roche’s monoclonal antibody (mAb) cancer treatment Avastin (bevacizumab).

 

Key Findings of the Report:

 

  • Global bevacizumab market expanding at significant CAGR over 2018 to 2024 owing to increasing prevalence of cancer diseases and rising aging population across the globe
  • Based on region, North America bevacizumab accounted for larger market revenue share in 2018 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global bevacizumab market

 

Key Features of the Report:

 

  • The report provides granular level information about the market size, regional market share, historic market (2013-2018) and forecast (2019-2025)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Detailed Segmentation

 

By Application

  • Colorectal Cancer
  • Lung Cancer
  • Breast Cancer
  • Renal Cancer
  • Brain Cancer
  • Eye Diseases
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

 

Geography

North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA
  1. Executive Summary
  2. Global Bevacizumab Market Introduction
    • Global Bevacizumab Market – Taxonomy
    • Global Bevacizumab Market –Definitions
      • By Application
      • By Distribution Channel
      • By Region
  1. Global Bevacizumab Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Bevacizumab Market Dynamics – Factors Impact Analysis
  2. Global Bevacizumab Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Bevacizumab Market Forecast, By Application, 2014 – 2018 and Forecast, 2019 – 2025
    • Colorectal Cancer
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Lung Cancer
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Breast Cancer
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Renal Cancer
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Brain Cancer
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Eye Diseases
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Bevacizumab Market Forecast, By Distribution Channel, 2014 – 2018 and Forecast, 2019 – 2025
    • Hospital Pharmacy
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacy
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacy
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Bevacizumab Market Forecast, By Region, 2014 – 2018 and Forecast, 2019 – 2025
    • North America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia Pacific
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • The Middle East & Africa
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Bevacizumab Market – Opportunity Analysis Index, By Application, By Distribution Channel, and Region, 2019 – 2025
  2. North America Bevacizumab Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Application Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Colorectal Cancer
      • Lung Cancer
      • Breast Cancer
      • Renal Cancer
      • Brain Cancer
      • Eye Diseases
      • Others
    • Distribution Channel Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US
      • Canada
    • North America Bevacizumab Market – Opportunity Analysis Index, By Application, By Distribution Channel, and Country, 2019 – 2025
    • North America Bevacizumab Market Dynamics – Trends
  3. Europe Bevacizumab Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Application Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Colorectal Cancer
      • Lung Cancer
      • Breast Cancer
      • Renal Cancer
      • Brain Cancer
      • Eye Diseases
      • Others
    • Distribution Channel Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Europe Bevacizumab Market – Opportunity Analysis Index, By Application, By Distribution Channel, and Country, 2019 – 2025
    • Europe Bevacizumab Market Dynamics – Trends
  4. Asia Pacific Bevacizumab Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Application Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Colorectal Cancer
      • Lung Cancer
      • Breast Cancer
      • Renal Cancer
      • Brain Cancer
      • Eye Diseases
      • Others
    • Distribution Channel Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • China
      • Japan
      • India
      • ASEAN Counties
      • Philippines
      • Rest of Asia Pacific
    • Asia Pacific Bevacizumab Market – Opportunity Analysis Index, By Application, By Distribution Channel, and Country, 2019 – 2025
    • Asia Pacific Bevacizumab Market Dynamics – Trends
  5. Latin America Bevacizumab Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Application Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Colorectal Cancer
      • Lung Cancer
      • Breast Cancer
      • Renal Cancer
      • Brain Cancer
      • Eye Diseases
      • Others
    • Distribution Channel Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Mexico
      • Brazil
      • Argentina
      • Chile
      • Rest of Latin America
    • Latin America Bevacizumab Market – Opportunity Analysis Index, By Application, By Distribution Channel, and Country, 2019 – 2025
    • Latin America Bevacizumab Market Dynamics – Trends
  6. Middle East and Africa Bevacizumab Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Application Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Colorectal Cancer
      • Lung Cancer
      • Breast Cancer
      • Renal Cancer
      • Brain Cancer
      • Eye Diseases
      • Others
    • Distribution Channel Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • GCC Countries
      • South Africa
      • Saudi Arabia
      • Turkey
      • Rest of MEA
    • Middle East and Africa Bevacizumab Market – Opportunity Analysis Index, By Application Type, By Distribution Channel, By Ingredient Type, By Application, and Country, 2019 – 2025
    • Middle East and Africa Bevacizumab Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)
      • Genentech
      • Amgen
      • Allergan
      • Hoffmann-La Roche AG
      • Pfizer
      • Biocon
      • Celgene Corporation
      • Enzon Pharmaceuticals
  1. Research Methodology
  2. Key Assumptions and Acronyms

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR

CALL US ON : 123456789

$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials